US 10493092
Antisense compounds
granted A61KA61K31/712A61K31/7125
Quick answer
US patent 10493092 (Antisense compounds) held by Ionis Pharmaceuticals, Inc. expires Mon Nov 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Dec 03 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 31
- CPC classes
- A61K, A61K31/712, A61K31/7125, A61P, A61P43/00